Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;10(8):708-16.
doi: 10.1080/15592294.2015.1060389.

Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero

Carmen J Marsit  1 , Sean S Brummel, Deborah Kacanek, George R Seage 3rd, Stephen A Spector, David A Armstrong, Barry M Lester, Kenneth Rich; Pediatric HIV/AIDS Cohort Studies Network
Collaborators, Affiliations

Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero

Carmen J Marsit et al. Epigenetics. 2015.

Abstract

The use of combination antiretroviral therapy (cART) to prevent HIV mother-to-child transmission during pregnancy and delivery is generally considered safe. However, vigilant assessment of potential risks of these agents remains warranted. Epigenetic changes including DNA methylation are considered potential mechanisms linking the in utero environment with long-term health outcomes. Few studies have examined the epigenetic effects of prenatal exposure to pharmaceutical agents, including antiretroviral therapies, on children. In this study, we examined the methylation status of the LINE-1 and ALU-Yb8 repetitive elements as markers of global DNA methylation alteration in peripheral blood mononuclear cells obtained from newborns participating in the Pediatric HIV/AIDS Cohort Study SMARTT cohort of HIV-exposed, cART-exposed uninfected infants compared to a historical cohort of HIV-exposed, antiretroviral-unexposed infants from the Women and Infants Transmission Study Cohort. In linear regression models controlling for potential confounders, we found the adjusted mean difference of AluYb8 methylation of the cART-exposed compared to the -unexposed was -0.568 (95% CI: -1.023, -0.149) and for LINE-1 methylation was -1.359 (95% CI: -1.860, -0.857). Among those exposed to cART, subjects treated with atazanavir (ATV), compared to those on other treatments, had less AluYb8 methylation (-0.524, 95% CI: -0.025, -1.024). Overall, these results suggest a small but statistically significant reduction in the methylation of these repetitive elements in an HIV-exposed, cART-exposed cohort compared to an HIV-exposed, cART-unexposed historic cohort. The potential long-term implications of these differences are worthy of further examination.

Keywords: DNA methylation; HIV; anti-retroviral; atazanavir; developmental origins; newborn; pediatrics; pharmaceuticals; prenatal; repetitive elements.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Distributions of (A) LINE-1 and (B) AluYb8 methylation extent at individual CpG sites, and the mean across the sequenced regions with and without batch adjustment
See this image and copyright information in PMC

References

    1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.. Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment. Pediatric Aids Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173–80; PMID:7935654; http://dx.doi.org/10.1056/NEJM199411033311801 - DOI - PubMed
    1. Hurst SA, Appelgren KE, Kourtis AP. Prevention of Mother-to-Child Transmission of Hiv Type 1: The Role of Neonatal and Infant Prophylaxis. Expert Rev Anti Infect Ther 2015; 13:169–81; PMID:25578882; http://dx.doi.org/10.1586/14787210.2015.999667 - DOI - PMC - PubMed
    1. Stevens J, Lyall H. Mother to Child Transmission of Hiv: What Works and How Much Is Enough? J Infect 2014; 69 Suppl 1:S56–62; PMID:25438711; http://dx.doi.org/10.1016/j.jinf.2014.07.018 - DOI - PubMed
    1. Ciaranello AL, Seage GR 3rd, Freedberg KA, Weinstein MC, Lockman S, Walensky RP. Antiretroviral Drugs for Preventing Mother-to-Child Transmission of Hiv in Sub-Saharan Africa: Balancing Efficacy and Infant Toxicity. AIDS 2008; 22:2359–69; PMID:18981776; http://dx.doi.org/10.1097/QAD.0b013e3283189bd7 - DOI - PMC - PubMed
    1. Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, et al.. Lack of Long-Term Effects of in Utero Exposure to Zidovudine among Uninfected Children Born to Hiv-Infected Women. Pediatric Aids Clinical Trials Group Protocol 219/076 Teams. JAMA 1999; 281:151–7; PMID:9917118; http://dx.doi.org/10.1001/jama.281.2.151 - DOI - PubMed

Publication types

MeSH terms

Substances